Avatar
NASDAQ Stock Market News source @nasdaq.com · New York City 🇺🇸· Jan 5

#GSK #COPD #Mepolizumab

Link Preview
www.nasdaq.com
GSK's Nucala Approved In China For Adult COPD Treatment
(RTTNews) - GSK plc (GSK, GSK. L) announced that China's National Medical Products Administration (NMPA) has approved Nucala (mepolizumab) as add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease or COPD characterised by raised blood eosinophils.
Avatar
NASDAQ Stock Market News source @nasdaq.com · New York City 🇺🇸· Jan 5

#GSK #COPD #Mepolizumab

Link Preview
www.nasdaq.com
GSK's Nucala Approved In China For Adult COPD Treatment
(RTTNews) - GSK plc (GSK, GSK.